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for (p)rehabilitation  including  a home-based  component  for patients  with  non-small  cell  lung  cancer
(NSCLC).  PRISMA  and  Cochrane  guidelines  were  followed.  Studies  describing  (home-based)  prehabilita-
tion  or  rehabilitation  in  patients  with  NSCLC  were  included  from  four  databases  (January  2000–April
2016,  N  = 11).  Nine  of ten  rehabilitation  studies  and  one  prehabilitation  study  (437  NSCLC  patients,
mean  age  59–72  years)  showed  significantly  or  clinically  relevant  improved  physical  fitness.  Three  (27%)
assessed  home-based  training  and  eight  (73%)  combined  training  at home,  inhospital  (intramural)  and/or
at the  physiotherapy  practice/department  (extramural).  Six (55%)  applied  supervision  of  home-based
∗ Corresponding author at: Department of Clinical Epidemiology, VieCuri Medical Centre, P.O. Box 1926, 5900 BX Venlo, The Netherlands.
E-mail addresses: ldriessen@viecuri.nl, research@viecuri.nl (E.J. Driessen), mariekepeeters13@hotmail.com (M.E. Peeters), bart.bongers@maastrichtuniversity.nl
B.C. Bongers), h.maas@etz.nl (H.A. Maas), g.bootsma@zuyderland.nl (G.P. Bootsma), meeteren@health-holland.com (N.L. van Meeteren), mjanssenheijnen@viecui.nl
M.L. Janssen-Heijnen).
ttp://dx.doi.org/10.1016/j.critrevonc.2017.03.031
040-8428/© 2017 Elsevier B.V. All rights reserved.
64 E.J. Driessen et al. / Critical Reviews in Oncology/Hematology 114 (2017) 63–76
Physical therapy
Compliance
Tolerance
Home
components,  and  four (36%)  a  personalized  training  program.  Adherence  varied  strongly  (9–125%  for
exercises,  50–100%  for patients).  Treatment  tolerance  and  recovery  were  heterogeneously  reported.
Although promising  results  of  (p)rehabilitation  for  improving  physical  fitness  were  found  (especially  in
case  of supervision  and  personalization),  adequately  powered  studies  for  home-based  (p)rehabilitation
are needed.
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. Introduction
Non-small cell lung cancer (NSCLC) concerns 85% of all lung
ancer patients (Netherlands Cancer Registry, 2016a). Five-year
urvival rates remain low ranging from 55%, 41%, 13%, to 2% for
tage I, II, III and IV, respectively (Netherlands Cancer Registry,
016b). Standard curative treatments, including lung resec-
ion (Vansteenkiste et al., 2014) and concurrent chemoradiation
Eberhardt et al., 2015), lead to adverse events in ≥50% of patients
nd frequently require hospitalization (Janssen-Heijnen et al.,
004; Schild et al., 2003). High age (Netherlands Cancer Registry,
016c), smoking-related comorbidities, frailty, poor performance
tatus, and long-term physical inactivity are often present in
atients with NSCLC (Janssen-Heijnen et al., 2004; Hsu et al., 2015;
emrau et al., 2014; Granger et al., 2014). These characteristics
ay  affect mobility, independence, treatment tolerance, recovery,
nd prognosis (Gridelli et al., 2007; Cardenal et al., 2015; Glotzer
t al., 2013; Kale et al., 2015; Hoogeboom et al., 2014). Resistance
nd endurance training can increase the functional and physiolog-
cal reserve, thereby creating a safety margin to meet potential
nlarged demands of cardiac output and other physical capaci-
ies at the time of disease and interventions (Hoogeboom et al.,
014; Carli and Zavorsky, 2005). Prehabilitation (therapeutic train-
ng before undergoing treatment) (Carli and Zavorsky, 2005) and
ehabilitation (therapeutic training during and after treatment)
Spruit et al., 2013) can optimize physical fitness, treatment tol-
rance, recovery, and survival (Singh et al., 2013; Ni et al., 2016;
ade et al., 2015), even in older cancer patients (Chou et al., 2012;
ack et al., 2011; Kilari et al., 2016). However, intramural training
inhospital) or extramural training (at the physiotherapy practice
r department) may  counteract compliance of high-risk patients
ecause of commuting problems, accessibility of services, multi-
orbidity, and vulnerability (Temel et al., 2009; Oosting et al.,
012). A personalized training program in a home-based setting
ight overcome these barriers and enhance both motivation and
dherence, especially for vulnerable and older patients (Bade et al.,
015). Therefore, the aim of this study is to systematically review
he literature regarding feasibility and effectiveness of prehabil-
tation and rehabilitation including a home-based component in
atients with NSCLC by evaluating physical fitness, and to describe
dherence and treatment tolerance, and recovery.
. Methods
The Cochrane guidelines for systematic reviews (The Cochrane
ollaboration, 2011) and PRISMA guidelines (Preferred Reporting
tems for Systematic Reviews and Meta-Analyses) (Moher et al.,
009) were followed. Databases Pubmed, Medline, Embase, and
EDro were searched for eligible articles describing patients with
SCLC undergoing prehabilitation or rehabilitation including a
ome-based component focusing on physical fitness (Table 1).
earch terms were explored on free text words to avoid exclu-
ion of recently published articles. Inclusion was limited to studies
n English or Dutch language between January 1, 2000 and April
1, 2016. The primary outcome was physical fitness and secondary
utcomes were patient adherence, exercise adherence, treatment© 2017  Elsevier  B.V.  All  rights  reserved.
tolerance, and recovery. Studies were excluded when insufficient
training information was available to distinguish prehabilitation
and rehabilitation, and when no physical intervention was applied.
2.1. Study selection
All search results were combined and duplicates removed.
Assessment of title, abstract and full-texts according to eligibility
criteria was  performed independently by reviewers MP  and ED.
Inclusion of eligible studies was discussed until consensus. If no
consensus was reached, a third person (BB) determined eligibil-
ity. Studies were included when full-text was  available. Reference
tracking was performed after full-text assessment in order to
include additional relevant studies.
2.2. Data collection process and items
For each included article, the following information was
independently collected, compared, and combined: first author,
publication year, study type (prehabilitation/rehabilitation, coun-
try, type of study, randomization), demographics (number of
patients with NSCLC, stage of disease, age, sex, treatment,
comorbidity, performance status), description of the intervention
(exercise content, frequency, intensity, measurement times, exer-
cise time, follow-up, time of delivery, controls), and outcomes
(physical fitness, patient adherence, exercise adherence, treatment
tolerance, recovery). Physical exercises consisted of resistance
and endurance training, and training effects were mainly evalu-
ated by the 6-minute walk test (6MWT) distance. Results were
described as mean ± standard deviation, mean (range), or mean dif-
ference ± standard deviation. A minimal clinically important gain of
≥42 m or 9.5% change was  considered clinically relevant for 6MWT
distance (Granger et al., 2015). Patient adherence was described;
both patient and exercise adherence (percentage) were consid-
ered sufficient above 70%. Treatment tolerance and recovery were
displayed by adverse events (numbers, including postoperative
complications) and hospitalization time (days, mean ± standard
deviation). Differences between outcomes were considered statis-
tically significant if P < 0.05.
2.3. Qualitative and quantitative assessment
Methodological quality was  independently assessed by using
the domain-based evaluation for systematic reviews by the
Cochrane ‘Risk of bias tool’ (Cochrane Statistical Methods
Group and Cochrane Bias Methods Group, 2011a). Selection-,
performance-, detection-, attrition-, and reporting bias were scored
present (+) or absent (−). Low, moderate, or high risk of bias was
determined by the percentage of present bias, corresponding to
high (≤17%), moderate (18–33%), or low (≥50%) methodological
quality, respectively. Therapeutic validity for quality of the train-
ing content was  assessed by the CONTENT scale (Consensus on
Therapeutic Exercise Training) (Hoogeboom et al., 2012; Herbert
and Bø, 2005). Nine items regarding patient eligibility, compe-
tences and setting, rationale of the study, content of the study,
and adherence were scored as performed (+) or not performed
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Table  1
Combinations of text words per database of the literature search.
Databases Population
Non-small cell lung cancer patients
Intervention
Home-based (p)rehabilitation
Outcome
Physical fitness
Embase, Pubmed, Medlinea (Non-small cell lung cancer OR NSCLC
OR lung cancer)
AND
(patient OR geriatric OR elderly OR
aged OR high-risk OR vulnerable OR
frail)
NOT
(children OR caregiver OR tuberculosis
OR aneurysm)
(prehabilitation OR before OR prior to
OR presurgical OR preoperative OR
during OR undergoing OR
rehabilitation OR perioperative OR
following OR postoperative OR lung
resection OR lobectomy OR physical
therapy OR training OR exercise OR
physiotherapy OR physical therapy
modality)
AND
(home-based OR living environment
OR outpatient OR home OR
home-based intervention)
NOT
(costs OR lung cancer screening OR
drug-reimbursement OR homeopathy
OR oxygen OR video-assisted)
(Physical activity OR fitness OR
physical function OR functional status
OR ADL OR strength OR  resistance OR
physical endurance)
NOT
(Genetic OR genomic OR gene OR
radon OR air pollution OR  asbestos OR
cell dynamics OR drug-resistance OR
smoking)
PEDroa Lung cancer Exerciseb AND homeb
age (
i d by ‘
(
i
w
g
2
s
e
3
s
s
e
n
(
a
e
C
e
d
3
N
R
5
s
t
A
G
e
s
2
i
a
2
(
p
n
a Free text words were applied to all search terms; filters were applied to langu
ncluded); search terms for population, intervention and outcome were all combine
b Truncation of search terms.
−), where ≥6 times ‘performed’ indicated high therapeutic valid-
ty. The interobserver agreement was calculated by Cohen’s Kappa,
ith poor (<0.20), reasonable (0.21–0.40), moderate (0.41–0.60),
ood (0.61–0.80) or very good (>0.80) agreement (Petrie and Sabin,
009). A meta-analysis could not be performed due to clinical and
tatistical heterogeneity in patient samples, exercise design, study
xecution, and reporting of physical outcomes.
. Results
The literature search identified 141 hits, leading to 107 unique
tudies of which 74 did not meet inclusion criteria. Thirty-three
tudies were selected for full-text assessment and 24 of them were
xcluded (conference paper with no available full-text version,
 = 16), no physical outcome (n = 3), no home-based intervention
n = 2) or other reasons (n = 3). Reference tracking identified two
dditional articles. Eventually, 11 studies were included (Andersen
t al., 2011, 2013; Arbane et al., 2011, 2014; Brocki et al., 2014;
heville et al., 2013; Coats et al., 2013; Granger et al., 2013; Hoffman
t al., 2014; Kuehr et al., 2014; Quist et al., 2012). The PRISMA flow
iagram is shown in Fig. 1 (Moher et al., 2009).
.1. Study characteristics
Fourhundred-fiftyone lung cancer patients were included (97%
SCLC) with various stages of disease and treatment regimens.
anges for sample size and mean age were 5–131 participants and
9–72 years, respectively. In Table 2, characteristics of included
tudies are displayed.
Only one study described prehabilitation (Coats et al., 2013) and
en studies described rehabilitation (Andersen et al., 2011, 2013;
rbane et al., 2011, 2014; Brocki et al., 2014; Cheville et al., 2013;
ranger et al., 2013; Hoffman et al., 2014; Kuehr et al., 2014; Quist
t al., 2012). Home-based training alone was examined in three
tudies (27%) (Cheville et al., 2013; Coats et al., 2013; Hoffman et al.,
014). One study (9%) combined home-based and extramural train-
ng (Brocki et al., 2014), six studies (55%) combined home-based
nd intramural training (Andersen et al., 2011, 2013; Arbane et al.,
011, 2014; Kuehr et al., 2014; Quist et al., 2012), and one study
9%) combined all three (Granger et al., 2013). The intervention
eriod lasted four to 16 weeks. The home-based training compo-
ent mainly consisted of resistance exercises (muscle strength) andEnglish and Dutch included) and publication date (Jan-1-2000 until Apr-11-2016
AND’.
endurance exercises (cardiorespiratory fitness) (Arbane et al., 2011;
Brocki et al., 2014; Cheville et al., 2013; Coats et al., 2013; Granger
et al., 2013; Hoffman et al., 2014; Kuehr et al., 2014), or mere walk-
ing (Andersen et al., 2011, 2013; Arbane et al., 2014; Quist et al.,
2012). Only four interventions (36%) were personalized (Andersen
et al., 2013; Arbane et al., 2011; Granger et al., 2013; Hoffman et al.,
2014). Supervision was  performed by telephone calls (Arbane et al.,
2014; Cheville et al., 2013; Coats et al., 2013; Granger et al., 2013;
Hoffman et al., 2014; Kuehr et al., 2014), home visits (Arbane et al.,
2014; Granger et al., 2013; Hoffman et al., 2014), or during intra-
mural sessions (Andersen et al., 2011, 2013; Arbane et al., 2014;
Brocki et al., 2014; Kuehr et al., 2014; Quist et al., 2012). The num-
ber of home-based training sessions varied between twice a week
(Brocki et al., 2014; Cheville et al., 2013) and once a day (Andersen
et al., 2013; Arbane et al., 2014; Brocki et al., 2014; Granger et al.,
2013), and moderate intensity was  mainly applied. Intramural and
extramural training consisted of supervised endurance training
combined with resistance exercises. The number of sessions var-
ied from twice a day postoperatively (Arbane et al., 2011; Granger
et al., 2013) to once a week (Brocki et al., 2014), from 10 to 30 min
(Granger et al., 2013) up to 1.5 h (Andersen et al., 2011, 2013) at
moderate or high intensity. These sessions took place during hos-
pitalization after surgery followed by home-based training alone
(Arbane et al., 2011, 2014; Brocki et al., 2014), intramural training
combined with concurrent home-based exercises (Andersen et al.,
2011; Kuehr et al., 2014; Quist et al., 2012), or intramural train-
ing with home-based exercises in between (Andersen et al., 2013;
Granger et al., 2013). Five studies (45%) included a control group
that received regular care (Arbane et al., 2011, 2014; Granger et al.,
2013), home-based exercises (Brocki et al., 2014), or no exercises
(Cheville et al., 2013).
Physical fitness was  mainly measured by cardiorespiratory fit-
ness (6MWT  distance) (Arbane et al., 2011; Brocki et al., 2014; Coats
et al., 2013; Granger et al., 2013; Hoffman et al., 2014; Kuehr et al.,
2014; Quist et al., 2012) and muscle strength (kilogram of resis-
tance per muscle group) (Arbane et al., 2011, 2014; Coats et al.,
2013; Kuehr et al., 2014; Quist et al., 2012). All studies (100%)
reported patient adherence (percentage) and most described rea-
sons for drop-out. Six studies (55%) reported on compliance of
home-based exercises (percentage) (Brocki et al., 2014; Cheville
et al., 2013; Granger et al., 2013; Hoffman et al., 2014; Kuehr et al.,
2014; Quist et al., 2012). Treatment tolerance and recovery were
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Table 2
Description of demographics and results of included (home-based) (p)rehabilitation studies.
First author,
year
Study type
1. (P)rehabilitation
2.  Country
3.  Type of study
4. Randomization
Demographics (IG/CG) Intervention exercise (IG/CG) Intervention
1. Measurement times
2. Exercise time (min)
3. Follow-up
4. Delivery
Outcomes (IG/CG)
1. Physical fitness
2. Patient adherence (drop-out)
Exercise adherence (compliance)
3. Treatment tolerance and recovery
Andersen, 2011 1. Rehabilitation
2.  Denmark
3.  PCT
4.  NA
N = 24
NSCLC N = 19
Age mean (range)
Men  64 (55–77)
Women  67 (48–76)
Treatment N
Surgery 5, CT 19, RT 8, TKI1
Home-based
5/wk for 7 weeks unsupervised
diary-based aerobic
(walking) + breathing
Intramural (simultaneously)
2/wk for 7 weeks supervised
group sessions, aerobic
(walking (85%
VO2max)) + breathing
Control NA
1. T0 1st supervised training
T1 last supervised training
2.  Home training NR;
Intramural 90
3. Wk1-10/11
4. After surgery; during CT, RT,
or  TKI
1. ISWT med  diff (range) +9% (−77; 39%)
P = 0.021
ESWT med  diff (range) +109% (−70; 432%)
P = 0.002
FEV1 med diff (range) 0% (−0.3; 0.6%) P = NR
2. Drop-out with reasons (N) home-based
NR; intramural
29%, <65% of sessions present (3),
incomplete data ISWT (4)
Compliance (N) NR; continued after
intervention (7)
3. NR
Andersen, 2013 1. Rehabilitation
2.  Denmark
3.  PCT
4.  NA
N = 51
NSCLC N = 39
Age mean ± SD
Men  65 ± 8, women 65 ± 7
Treatment N
Surgery 10, CT 26, RT 3, TKI 2
Intramural
2/wk for 3 weeks aerobic
(cycling and walking (Borg RPE
16–18)) + breathing
Repetition of this design after
home training
Home-based
7/wk for 3 weeks (between
intramural sessions)
personalized unsupervised
diary instructed
aerobic + breathing
Intramural
2/wk for 3 weeks intramural
regimen
Control NA
1. T0 1 t supervised training
T1 last supervised training
2.  Home training NR;
Intramural 90
3. Wk1–13
4. Unclear (after surgery);
during or after CT, RT, and TKI
1. VO2max (ml/O2/kg/min) mean ± SD T0
14 ± 3 T1 14 ± 3 P = 0.763
FEV1 (L) mean ± SD T0 2.0 ± 0.6 T1 2.0 ± 0.5
P  = NS
2. Drop-out with reasons (N) 43%,
withdrawal after first session
(7), withdrawal after home sessions (9),
<65% present at
second session (6); After intervention, not
continuing physical activity (8), LFU (3)
Compliance (N) NR; continued after
intervention (18)
3. NR
Arbane,  2011 1. Rehabilitation
2.  UK
3.  RCT
4.  Block randomization
N = 26/25
NSCLC N = 26/25
Stage N
I  15/10, II 6/6, III 2/0, IV 0/5, NR
3/4
Age mean (range)
62.6 (32–47)/65.4 (47–82)
Sex NR
Treatment N
Surgery 26/25
Intramural
2/day for 5 days postoperative
mobility + resistance (seated
leg raises) + aerobic (walking,
cycling 60–80% HRx)
Home-based
12 weeks personalized (based
on hobbies) aerobic
(walking) + strength (not
specified) with monthly
supervision/home visit
Control
Monthly check-up calls and
usual care including
breathing + mobilization
1. T0 preoperative
T1 postoperative
day5
T2 postoperative
wk12
2. NR
3. Preoperative-
postoperative wk12
4. After surgery
1. 6MWT  (m) mean ± SD T0 466.6 ± 1021/
4557 ± 98.0;
T1 336.7 ± 84.1/308.7 ± 124.8; T2
480.2 ± 110.0/448.2 ± 95.1
P  = 0.89§; P < 0.00†
Quads strenght (kg) mean ± SD T0
33.2 ± 15.2/ 29.1 ± 10.9;
T1  37.6 ± 27.1/21.5 ± 7.7; T2
34.2 ± 9.4/26.4 ± 9.7; P = 0.04*; P = 0.70†
2. Drop-out with reasons (N) 15%/32%, IG:
palliative care (1), no surgery (1), refused
measurement (1), no reason (1);
CG: ITU admission (1), no reason (1),
palliative care (1), withdrawal (1), refused
(3)
Compliance (N) NR
3. Length of hospital stay (days) mean ± SD
8.9 ± 3.3/11.0 ± 8.9
P = NR; A priori post-operative
complications (N) 2/3 P = NR
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Arbane, 2014 1. Rehabilitation
2. UK
3. RCT
4. Online
randomization
N = 64/67
NSCLC N = 64/67
Stage N I 24/ 29, II 12/12, III
6/8, IV 7/2, NR 15/16
Age mean ± SD
67 ± 11/68 ± 11
Sex N(%) female
35(55)/24(36)
Treatment N
Surgery 64/67
Comorbidities N(%)
COPD 34(53)/29(43)
Intramural
1/day for 5 days postoperative
supervised strength (ankle lift
(10-RM)) + aerobic cycling
(max 60% heart rate reserve),
intensity increases daily
Home-based
7/wk for 4 weeks unsupervised
walking by pedometer and
weekly calls
Control
Monthly check-up calls and
usual care including pain relief
by  breathing and mobilization
exercises
1. T0 preoperative
T1 postoperative
day5
T2 postoperative
wk4
2. Home training 30
Intramural 30
3. Preoperative-postoperative
wk4
4. After surgery
1. ISWT (m)  med(IQR) T0
290(180–440)/290(200–450); T1
110(NR)/135(NR); T2 350(NR)/290(NR);
P  > 0.05‡; P > 0.05§
Quads strength (kg) mean change diff(95%BI)
T2  4.7(0.18–0.20); P = 0.04‡ in COPD patients
2. Drop-out with reasons (N) 38%/43% IG:
inoperable (3), no cancer (6), ITU admission
(4), withdrawal (6), moved (1), rehospitalized
(1), deceased (1), failed activity monitor (2);
CG: inoperable (4), no cancer (1), no NSCLC (2),
deceased (4), ITU admission (9), refusal (1),
withdrawal (2), additional surgery (1), moved
(1), failed activity monitor (4)
Compliance (N) NR
3. Length of hospital stay (days) mean(range)
7.5(5–8)/7.1(6–8) P > 0.05‡
A priori postoperative complications (n(%))
20(31)/22(33) P = NR
Brocki,  2014 1. Rehabilitation
2. Denmark
3. RCT
4. Computer-generated
randomization tables
N = 39/39
NSCLC N = 39/36
Stage N I 16/10, II 17/14, III 4/7,
unknown 2/15
Age mean ± SD
64 ± 10/65 ± 9
Sex N(%) female
19(46)/13(35)
Treatment N
Surgery 41/37
Comorbidities N
COPD 8/5, DM 5/3, CVD 8/12,
previous malignancy 12/13
Extramural
1/wk for 10 weeks starting
wk3 postoperative supervised
group aerobic (walking with
increasing inten-
sity) + strength + breathing
Home-based
(simultaneously)
2/wk strength + 7/wk aerobic
(walking, cycling (BORG RPE
11–12)) diary based;
wk3–4months postoperative
Control
2/wk strength + 7/wk aerobic
(walking, cycling (BORG RPE
11–12)) diary based at home
1. T0 postoperative wk3
T1 4 months after baseline
T2 1 year after baseline
2. Home training 30
Extramural 60
3. Baseline-12 months after
baseline
4. After surgery
1. 6MWT  (m)  mean ± SD T0
427 ± 124/407 ± 102;
T1 mean diff baseline 61 ± 52/55 ± 45 P = 0.57‡
T2 mean diff baseline 65 ± 70/60 ± 45 P = 0.93‡
FEV1 (L) mean ± SD T0 1.73 ± 0.5/1.9 ± 0.6;
T1 mean diff baseline 0.14 ± 0.3/0.1 ± 0.4
P  = 0.84‡
T2 mean diff baseline 0.1 ± 0.4/0.06 ± 0.4
P  = 0.84‡
2. Drop-out with reasons (N) 28%/14% IG:
deceased (3), withdrawal (8); CG: deceased (2),
withdrawal (3)
Compliance Home-based (IG/CG %) 43%/14%;
extramural (IG N) 17 in 10 sessions, 8 in 9, 5 in
8 and 2 in 6–7 sessions
3. Length of hospital stay (days) mean ± SD
9  ± 5/10 ± 5 P = NR
Cheville, 2013 1. Rehabiliation
2. United States
3.  RCT
4. Unblinded block
randomization
N = 26/33
Lung cancer N = 16/18
Stage N IV 26/33
Age mean ± SD
63.8 ± 12.5/65.5 ± 8.9
Sex N(%) female
17(51.5)/14(42.4)
Treatment N (NR 5/4)
RT 4/4, CT 24/25
Home-based
2/wk for 8 weeks strength
(Borg CR10) + 4/wk for 8 weeks
aerobic (walking, 1
mile/20 min) diary based and
every two  weeks check-up calls
Control
No exercises or monitoring
during intervention period
1. T0 wk1
T1 wk8
2. Home training 20
3. Baseline-12 months
4. During (palliative)
treatment
1. Mobility mean diff ± SD 4.88(4.66)/0.23(5.22)
P = 0.002
Activity mean diff ± SD 1.56 ± 5.53/0.94 ± 5.91
P = 0.74
Steps/day (N) mean T0 3200/NR; T1 4400/NR;
P = NR
*Self-reported Ambulatory Post Acute Care
Daily Activities Short Form
2. Drop-out with reasons (N) 27%/9% IG:
deceased (5), LFU (1),
fracture (1); CG:  deceased (2), LFU (1)
Compliance (N) IG: 26, 77%
3. No adverse events during home-based
program, difference deceased participants
IG/CG NS
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Table 2 (Continued)
First author,
year
Study type
1.  (P)rehabilitation
2. Country
3. Type of study
4. Randomization
Demographics (IG/CG) Intervention exercise (IG/CG) Intervention
1. Measurement times
2. Exercise time (min)
3. Follow-up
4. Delivery
Outcomes (IG/CG)
1. Physical fitness
2.  Patient adherence (drop-out)
Exercise adherence (compliance)
3. Treatment tolerance and recovery
Coats, 2013 1. Prehabilitation
2. Canada
3. PCT
4. NA
N = 13
NSCLC N = 13
Stage N I 5, II 4, III 0, IV 2
Age mean ± SD 59 ± 9
Sex N female 5
Treatment N
Awaiting surgery 10, CT 1, CT
palliative 1, RT + CT palliative 1
Comorbidities N
COPD 5, hypertension 5,
dyslipidemia 3, DMII 2, anxiety
2
Home-based
3–5/wk for 4 weeks diary
based aerobic (cycling (Borg
BS≥6)) + strength and weekly
check-up calls
Control NA
1. T0 baseline
T1 wk4
2. Home training 30
3. Wk1–4
4. Before treatment
1. VO2max (mL/kg/min) mean ± SD T0
21.6 ± 7.8; T1 23.3 ± 7.5 P > 0.05
VO2max (L/min) mean ± SD T0 1.63 ± 7.8; T1
1.75 ± 0.71 P > 0.05
CWCE (s) mean ± SD T0 264 ± 79; T1 421 ± 241
P  < 0.05
6MWT(m) mean ± SD T0 540 ± 98; T1
568 ± 101 P < 0.05
Muscle strength (kg) mean increase (SD); % ± SD
m. deltoideus: 1.82 ± 2.83; 18 ± 31; P < 0.05; m.
triceps: 1.32 ± 1.75;
14 ± 25; P < 0.05; m.  hamstrings: 3.41 ± 3.7;
27  ± 40; P < 0.05; Handgrip, m. biceps and m.
quadriceps NS
2. Drop-out with reasons (N) 0%
Compliance (%) Aerobic (125); strength (84);
recruitment (50)
3. No adverse events
Granger, 2013 1. Rehabilitation
2. Australia
3. RCT
4. Computer-generated
randomization tables
N = 7/8
NSCLC N = 2/5
Age mean ± SD
57 ± 16.2/72.4 ± 12.4
Sex % female
57.1/37.5
Treatment N
Surgery 7/8
Intramural
From postoperative until
discharge aerobic (walking
(Borg BS 4) 2/day, cycling
1/day) + strength (Borg RPE 13)
1/day
Home-based
7/wk for 2 weeks after
discharge personalized aerobic
(walking (Borg BS
4)) + strength 1/wk check-up
calls and 3 home visits
Extramural
2/wk for 8 weeks after home
training aerobic (walking and
cycling (Borg BS 4)) + strength
(Borg RPE 13)
Control Standard
care + breathing
1. T0 preoperative<2wk
T1 postoperative wk2
T2 postoperative
wk12
2. Home training 30
Intramural 10–30
Extramural 30
3. Preoperative-
wk12
4. After surgery
1. 6MWT  (m) mean ± SD T0
677.0 ± 89.3/435.8 ± 98.2;
T1 647.5 ± 53.1/426.0 ± 64.3; T2
705.7 ± 65.3/458.2 ± 38.6
P  = 0.024‡ at T2; others NR
TUG (s) mean ± SD T0 6.3 ± 1.6/9.0 ± 2.6; T1
4.4 ± 2.6/6.0 ± 3.2;
T2 4.9 ± 0.8/6.8 ± 1.5 P = 0.041‡ at T2; others NR
2. Drop-out with reasons (N) 43%/38% IG: not
present for testing (1), LFU (2); CG: not present
for testing (2), LFU (1)
Compliance (%) home-based NR; intramural
(71); extramural (81)
3. Length of hospital stay (day) mean(range)
4(3–9)/6(3–17); P = NR
Hoffman,  2014 1. Rehabilitation
2. United States
3. PCT
4. NA
N = 5
NSCLC N = 5
Stage N IIA 1, IIB 2, IIIA 2
Age mean ± SD 63.4 ± 7.3
Sex N female 3
Treatment N
Surgery+ CT 5
Karnofsky PS N
70% 2, 90% 3
Comorbidities mean N (range)
5.4 (2–12)
Home-based
5/wk for 16 weeks from day 4
post-operative personalized
aerobic (walking
(≤3MET)) + balance by
Nintendo Wii  Fit. Two home
visits and weekly check-up
calls
Control NA
1. T0 preoperative
T1 postoperative wk5
T2 postoperative
wk16
2. home-training 5 + daily 5
increase
3. Baseline-wk16
4. After surgery and during CT
1. 6MWT  (m) mean ± SD T0 413 ± 32; T1
382 ± 108; T2 463 ± 62 P = NR
Walking time (min) mean ± SD T0 NR; T1
24.0 ± 4.3; T2 31.0 ± 6.5 P = NR
2.  Drop-out 0%
Compliance % ± SD(range) Walking 92.6 ± 4.6
(87.0–98.1); Balance 94.7 ± 7.0 (82.5–100)
3.  Length of hospital stay (day)
mean ± SD(range) 8.4 ± 2.6(5–12) P = NR
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Kuehr, 2014 1. Rehabilitation
2. Germany
3. PCT
4. NA
N = 40
NSCLC N = 40
Stage N
IIA 2, IIIA 3, IIIB 8, IV 27
Age mean ± SD(range)
60 ± 12(22–75)
Sex N(%) female 16(40)
Treatment N
Surgery 3, concurrent CHRT 4,
sequential CHRT 1, CT 33
Intramural
5/wk for 8 weeks of which 3
times supervised aerobic
(walking, cycling (Borg RPE
12–14)) + strength (resistance
(Borg RPE 14–16))
Home-based
(simultaneously)
3/wk for 8 weeks diary based
aerobic (walking (Borg RPE
12–14)) + strength (resistance
(Borg RPE 14–16)) and weekly
check-up calls
Control NA
1. T0 baseline
T1 wk8
T2 wk16
2. Home training NR
Intramural NR
3. Baseline-wk16
4. After surgery, during
CHRT and CT
1. 6MWT(m) mean ± SD T0 493 ± 100; T1
525 ± 95 P < 0.01; T2 543 ± 120 P = 0.46
Knee flexion (Newton) mean ± SD T0 140 ± 41;
T1  177 ± 61
P < 0.01; T2 192 ± 57 P < 0.01
Knee extension (Newton) mean ± SD T0
201 ± 86; T1 279 ± 71
P < 0.01; T2 327 ± 116 P < 0.01
Other muscle strengths reported but NS
2. Drop-out with reasons (N) 50% T0 fatigue (4),
pneumonia (1), deceased (1), pain (1), infection
(1), stroke (1); T1 stress (4), moved (1),
metastases (1), dyspnea (1), pneumonia (1),
stopped treatment (1); T2 no time (4), LFU (5)
Compliance (%) overall (82), home-based (77),
intramural (95)
3. NR
Quist,  2012 1. Rehabilitation
2. Denmark
3. PCT
4. NA
N = 29
NSCLC N = 19
Age mean(range)
63(45–80)
Sex N(%) female 16(55.2)
Treatment N
CT 27, CHRT 2
Physical activity before
diagnosis N
Sedentary (2), <3 h/wk 14,
≥3 h/wk 12, >4 h/wk 1
Intramural
2/wk for 6 weeks supervised
strength (resistance (70–90%
1RM)) + aerobic (cycling
(85–95% max  HR)) + stretching
Home-based
(simultaneously)
3/wk for 6 weeks unsupervised
diary based aerobic
(walking) + relaxation
Control NA
1. T0 baseline
T1 wk6
2. Home training 20–60
Intramural 90
3. Baseline-wk6
4. During CT and CHRT
1. VO2max(L/min) mean ± SD T0 1.48 ± 0.41; T1
1.57 ± 0.41 P = 0.014
6MWT (m) mean ± SD T0 524.7 ± 88.5; T1
564.0 ± 88.6 P = 0.006
FEV1 (L) mean ± SD T0 1.76 ± 0.70; T1
1.96 ± 0.63 P = 0.061
Muscle strength(kg) mean ± SD Leg press: T0
70.34 ± 26.9; T1 86.9 ± 28.8
P = 0.000; Chest press T0 30.8 ± 13.2; T1
40.3 ± 16.3
P  = 0.000; Lat machine: T0: 35.8 ± 13.8; T1
39.2 ± 17.6 P = 0.049;
Abdominal crunch: T0 24.9(10.7); T1 29.5(11.3)
P  = 0.000; Lower
back: T0 35.3 ± 14.1; T1 43.1 ± 16.2 P = 0.000;
Leg extension:
T0 38.6 ± 15.5; T1 45.1 ± 18.9 P = 0.000
2. Drop-out with reasons (N) 21% Loss of
motivation (3), worsened PS(3)
Compliance (%) home-based 8.7%, intramural
73.3%
3. No adverse events
Abbreviations:  6MWT  = 6-Minute Walking Test; Borg BS = Borg CR 10 Breathlessness Scale; BORG RPE = Borg Rating of Perceived Exertion Scale; CG = Control Group; CHRT = CHemoRadioTherapy; CI = Confidence Interval;
COPD  = Chronic Obstructive Pulmonary Disorder; CR = Category Ratio; CT = ChemoTherapy; CVD = CardioVascular Disease; CWCE = Constant Workrate Cycle Exercise; diff = difference; DM = Diabetes Mellitus; ESWT = Endurance
Shuttle  Walk Test; FEV1 = Forced Expiratory Volume in 1 second; HR = Heart Rate; IG = Intervention Group; ISWT = Incremental Shuttle Walk Test; kg = kilogram; IQR  = Inter Quartile Range; L = Liter; LFU = Lost to Follow Up;
max  = maximal; m = meter; med = median; MET  = Metabolic Equivalents; min = minute; ml = milliLiter; N = Number; NA = Not Applicable; NR = Not Reported; NS = Not Significant; NSCLC = Non-Small Cell Lung Cancer; O2 = oxygen;
PCT  = Patient Cohort Trial; PS = Performance Status; RCT = Randomized Controlled Trial; RM = Repeat Maximum; RT = RadioTherapy; s = second; SD = Standard Deviation; subj = subjects; TKI = Tyrosin Kinase Inhihibitor (targeted
therapy);  UK = United Kingdom; VO2max = maximal oxygen uptake; WHO  = World Health Organization; wk = week.
† Within subjects group time effect.
‡ Between subjects group time effect.
§ Between groups.
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Table 3
Physical outcomes including significance and clinical relevance of changes of included studies according to measuring instruments.
Outcome unit First author, year Measurement times (IG/CG) Mean ±  SD; (range) 1. Absolute change [percentage] (IG/CG)
2.  Mean ± SD of  change (range) [95%CI] (IG/CG)
1. P-value
2.  Clinically relevant
changea
Baseline Postoperative End iv Post iv T0–T1 T0–T2 T1–T2
Prehabilitation –  cardiorespiratory fitness
VO2max mL/kg/min Coats, 2013 21.6 ± 7.8 23.3 ±  7.5 1. +1.7 [7.8%] 1. >  0.05
2. No
VO2max L/min Coats, 2013 1.63 ± 7.8 1.75 ±  0.71 1.  +0.12 [+7.4%] 1. >0.05
2. No
6MWT  m Coats, 2013 540 ± 98 568 ± 101 1. +28  [+5.2%]
2.  +28  ± 29
1. <  0.05
2. No
CWCE  s Coats, 2013 264 ± 79  421  ± 241 1.  +57  [+59.5%]
2.  +157  ± 195
1. <  0.05
2. yes
Rehabilitation  – cardiorespiratory fitness
VO2max mL/kg/min Andersen, 2013 14 ± 3  14 ± 3 1.  +0.0  [+0.0%] 1. 0.763
2. No
VO2max L/min Quist, 2012 1.48 ± 0.41 1.57 ±  0.41 1. +0.09 [+6.1%]
2.  +0.09 [0.02;0.16]
1. 0.014
2. NR
FEV1 L Andersen, 2013 2.0 ± 0.6 2.0 ±  0.5 1.  +0.0  [+0.0%] 1. NS
2. No
FEV1 L Brocki, 2014 1.73 ± 0.5/1.9 ± 0.6 Mean diff
0.14  ± 0.3/0.1 ±  0.4
Mean diff
0.1  ±  0.4/0.06 ± 0.4
1. +0.14/+0.1
[+8.1/+5.3%]
2.  0.02 [−0.14;0.17]§
1. +0.1/+0.06
[+5.8/+3.2%]
2. 0.02 [−0.14;0.18] §
1.  −0.04/−0.04 1. T1  0.84
T2  0.84
2.  No
FEV1  L  Quist, 2012 1.76 ± 0.7 1.96 ±  0.6 1.  +0.20 [+11.4%]
2.  0.20 [−0.01;0.41]
1. 0.061
2. No
6MWT  m Arbane, 2011 466.6 ± 102.1/
455.7 ± 98.0
D5 336.7 ± 84.1/
308.7 ± 124.8
480.2 ± 110.0/
448.2 ± 95.1
1. −129.9/ −147
[−27.8/  −32.3%]
1. +13.6/−7.5
[+2.9/−1.6%]
1. +143.5/+139.5
[+42.6/+45.2%]
1. <  0.001†;  0.89‡
2. Yes
6MWT  m Brocki, 2014 427 ± 124/ 407 ± 102 Mean diff
+61  ± 52/+55 ± 45
Mean diff
+65  ± 70/+60 ±  45
1. +61  ± 52/ +55  ± 45
[+14.3/+13.5%]
2.  8.33  [−20;36.27]
1. +65 ±  70/  +60  ±  45
[+15.2/+14.7%]
2.  1.31 [−28.18;30.8]
1. +4.0/+5.0 1. T1  0.57§
T2 0.93§
2. Yes
6MWT  m Granger, 2013 677.0 ± 89.3/
435.8 ± 98.2
Wk2 647.5 ±  53.1/
426.0 ± 64.3
705.7 ± 65.3/
458.2 ± 38.6
1. −29.5/−9.8
[−4.4/−2.3%]
1. +28.7/+22.4
[+4.2/+5.1%]
1. +58.2/+32.2
[+9.0/+7.6%]
1. T2  0.024§
2. Yes
6MWT  m Hoffman, 2014 413 ± 32
(367–452)
Wk5 382 ± 108
(202–480)
463 ± 62
(383–529)
1. −31  [−7.5%] 1. +50 [+12.1%] 1.  +81 [+21.2%] 1. NR
2. Yes
6MWT  m Kuehr, 2014 493 ± 100 525  ± 95 Wk 16
543  ± 120
1. +32  [+6.5%] 1. +50 [+10.1%] 1.  +18 [+3.4%] 1. T0–T1 <  0.01
T0–T2 0.46
2.  Yes
6MWT  m Quist, 2012 524.7 ± 88.5 564.0 ± 88.6  1.  +39.3  [+7.6%]
2.  +39.3  [12.5;66.1]
1. 0.006
2. No
ISWT  m Andersen, 2011 NR Med diff %
+9.0(−77;39)
2. +9.0% (−77;39) 1. 0.021
2. NR
ISWT  m Arbane, 2014 290(180–440)/
290(200–450)
D5 110/135 350/290 1.  −180/−155
[−62/−53%]
1. +60/+0 [+21/+0%] 1.  +250/+155
[+227/+115%]
1. >0.05§;  >0.05‖
2. Yes
ESWT  m Andersen, 2011 NR Med diff %
+9(−70;432)
2. +9% (−70;432) 1. 0.002
2. NR
Steps/day  n Cheville, 2013 3200 4400 1.  +1200 [+37.5%] 1. NR
2. NA
Walking  time min Hoffman, 2014 NR Wk 5  24.0 ± 4.3 31.0 ± 6.5 1.  +7.0 [+29%] 1. NR
2. NA
TUG  s Granger, 2013 6.3 ± 1.6/9.0 ± 2.6 Wk2 4.4 ± 2.6/
6.0  ± 3.2
4.9 ±  0.8/6.8 ± 1.5 1.  −1.9/−3.0
[−30.2/−30%]
1. −1.4/−2.2
[−22.2/−24.4%]
1. +0.5/+0.8
[+11.4/+13.3%]
1. 0.041§
2. No
Mobility  likert scale Cheville, 2013 NR/NR NR/NR 2.+4.88 ± 4.66[2.96;
−6.80]/
+0.23 ± 5.22[−1.76;2.22]
1. 0.002
2.  NA
Activity  likert scale Cheville, 2013 NR/NR NR/NR 2.
+1.56 ±  5.53[−0.72;3.82]
/+0.94 ±  5.91[−1.26;3.14]
1. 0.74§
2.  NA
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Prehabilitation – muscle strength
m.  deltoi-deus kg Coats 2013 NR NR 1. +1.82 ± 2.83
[+18.0% ± 31.0]
1. < 0.05
2. NA
m.  triceps kg Coats 2013 NR NR 1. +1.32 ± 1.75
[+14.0% ± 25.0]
1. < 0.05
2. NA
m.  ham-strings kg Coats 2013 NR NR 1. +3.41 ± 3.7
[+27.0% ± 40.0]
1. <0.05
2.  NA
Rehabilitation  – muscle strength
m.  quadri-ceps kg Arbane 2011 33.2 ± 15.2/
29.1 ± 10.9
D5 37.6 ± 27.1/
21.5 ± 7.7
34.2 ± 9.4/26.4 ± 9.7 1. +4.4/−7.6
[+13.3/−26.1]
1. +1.0/−2.7
[+3.0/−9.3%]
1. −3.4/+4.9
[−9.0/+22.8%]
1. 0.70‖; 0.04§
2. NA
Extension  knee N Kuehr 2014 201 ± 86 279 ± 71 Wk16
327 ± 116
1. +78[+38.8%] 1. +126[+62.7%] 1.  +48[+17.2%] 1. T0–T1 <0.01
T0–T2  <0.01
2.  NA
Extension  leg kg Quist et 2012 38.6 ± 15.5 45.1 ± 18.9 1. +6.5[+16.8%]
2. 6.5[4.1–8.9]
1. 0.000
2.  NA
Press  leg kg Quist 2012 70.34 ± 26.9 86.9 ± 28.8 1. +16.56[+23.5%]
2. +16.5[11.5–21.7]
1. 0.000
2.  NA
Extension  elbow N Kuehr 2014 124 ± 44 136 ± 44 Wk16
129 ± 41
1. +12[+9.7%] 1. +5[+4.0%] 1.  −7[−5.1%] 1. T0–T1 <0.01
T0–T2  0.49 2. NA
Flexion  knee N Kuehr 2014 140 ± 41 – 177 ± 61 Wk16
192 ± 57
1. +33[+23.6%] 1. +52[+37.1%] 1.  +15[+8.5%] 1. T0–T1 <0.01
T0–T2  <0.01
2.  NA
Flexion  elbow N Kuehr 2014 144 ± 52 – 152 ± 55 Wk16
158 ± 69
1. +8[+5.6%] 1. +14[+9.7%] 1.  +6[+3.9%] 1. T0–T1 0.02
T0–T2  0.68
2.  NA
Hip  flexion N Kuehr 2014 133 ± 48 – 137 ± 54 Wk16
135 ± 62
1. +5[+3.8%] 1.+2[+1.5%] 1.  −2[−1.5%] 1. T0–T1 0.21
T0–T2  0.26
2.  NA
Hip  abduction N Kuehr 2014 153 ± 45 – 164 ± 48 Wk16
161 ± 48
1. +11[+7.2%] 1. +8[+5.2%] 1.  −3[−1.8%] 1. T0–T1 <0.01
T0–T2  0.73
2.  NA
Chest  press kg Quist 2012 30.8 ± 13.2 – 40.4 ± 16.3 – 1. +9.6[+31.2%]
2. +9.5[6.4–12.7]
– –  1. 0.000
2.  NA
Lat  ma-chine kg Quist 2012 35.8 ± 13.8 – 39.2 ± 17.6 – 1. +3.4[+9.5%]
2. +3.4[0.0–6.7]
– –  1. 0.049
2.  NA
Abdominal  crunch kg Quist 2012 24.9 ± 10.7 – 29.5 ± 11.3 – 1. +4.6[+18.5%]
2. +4.6[3.2–6.0]
– –  1. 0.000
2.  NA
Lower  back kg Quist 2012 35.3 ± 14.1 – 43.1 ± 16.2 – 1. +7.8[+22.1%]
2. +7.8[4.8–10.8]
– –  1. 0.000
2.  NA
Abbreviations: 6MWT  = 6-Minute Walking Test; CG = Control Group; CI = Confidence Interval; CWCE = Constant workrate Cycle Exercise; D = day; diff = difference; ESWT = Endurance Shuttle Walk Test; FEV1 = Forced Expiratory Vol-
ume  in 1 second; IG = Intervention Group; ISWT = Incremental Shuttle Walk Test; iv = intervention; kg = kilogram; L = Liter; m = meter; MCID = Minimal Clinically Important Difference; med  = median; mL  = milliliter; min = minutes;
n  = Number; N = Newton; NA = Not Applicable; NS = Not Significant; NR = Not Reported; s = seconds; SD = Standard Deviation; T0 = baseline; T1 = first measurement time; T2 = last measurement time VO2max = maximum oxygen
uptake;  wk = week.
a MCID-values for aerobic outcomes: VO2max increase of 3.5 mL/min/kg (Myers et al., 2002); 6MWT  increase of ≥42 m or 9.5% change (Granger et al., 2015); CWCE increase of ≥100 s (Redelmeier et al., 1997); FEV1 increase of
0.23  L (Laviolette et al., 2008); ISWT increase of 70 m (Santanello et al., 1999); ESWT increase of 154–164 m (Houchen-Wolloff et al., 2015); TUG (s) decrease of ≥0.8 s (Altenburg et al., 2015); MCID-values not found for: Steps/day
(N);  Walking time (min); Mobility (likert scale); Activity (likert scale) and muscle strengths.
† Within subjects group time effect.
‡ Between subjects group time effect.
§ Between groups.
‖ Between measurement times.
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Fig. 1. PRISMA flow diagram displaying th
escribed as adverse events (including post-operative pulmonary
omplications) (Cheville et al., 2013; Coats et al., 2013), or hos-
italization days (Arbane et al., 2011, 2014; Brocki et al., 2014;
ranger et al., 2013; Hoffman et al., 2014). Other results of phys-
cal outcomes are displayed according to measuring instruments
n Table 3 (Myers et al., 2002; Redelmeier et al., 1997; Laviolette
t al., 2008; Santanello et al., 1999; Houchen-Wolloff et al., 2015;
ltenburg et al., 2015; Wright et al., 2011).
.2. Results of individual studies
The prehabilitation study and six rehabilitation studies (64%)
escribed significantly improved physical fitness after (home-
ased) training (Andersen et al., 2011; Arbane et al., 2011; Coats
t al., 2013; Granger et al., 2013; Kuehr et al., 2014; Quist
t al., 2012). Three additional rehabilitation studies (27%) indi-
ated improved physical fitness as well, although significance was
ot reported (Brocki et al., 2014; Cheville et al., 2013; Hoffman
t al., 2014). Specific outcomes are displayed in Table 2. The 6MWT
istance was described in seven studies (64%), including the preha-
ilitation study, and showed a significant improvement of 28–65 m
5.2–43%) (Arbane et al., 2011; Brocki et al., 2014; Coats et al., 2013;
ranger et al., 2013; Hoffman et al., 2014; Kuehr et al., 2014; Quist
t al., 2012). In five of them, this gain was clinically relevant (Arbane
t al., 2011; Brocki et al., 2014; Granger et al., 2013; Hoffman et al.,ction of studies and reasons for exclusion.
2014; Kuehr et al., 2014). Muscle strength increased significantly
during training sessions for most muscle groups (Arbane et al.,
2014; Coats et al., 2013; Kuehr et al., 2014; Quist et al., 2012). All
studies described patient adherence and varied from 50% (Kuehr
et al., 2014) to 100% (Coats et al., 2013; Hoffman et al., 2014). Main
reasons for dropout were clinical deterioration, incomplete data-
assessment, dying, and withdrawal from study-protocol. In all three
studies examining home-based training alone, patient adherence
was sufficient (72%, 100%, and 100%, respectively) (Cheville et al.,
2013; Coats et al., 2013; Hoffman et al., 2014). In three of eight
studies combining home-based with extramural and/or intramu-
ral training, patient adherence was sufficient (71%, 72%, and 79%,
respectively) (Andersen et al., 2011; Brocki et al., 2014; Quist et al.,
2012), and varied from 50 to 68% in the remaining five studies
(Andersen et al., 2013; Arbane et al., 2011, 2014; Granger et al.,
2013; Kuehr et al., 2014). Reported exercise adherence for the
home-based component varied from 9% (Quist et al., 2012) to 125%
(Coats et al., 2013) and was sufficient in four of six studies (Cheville
et al., 2013; Coats et al., 2013; Hoffman et al., 2014; Kuehr et al.,
2014). Six studies included adverse events or hospitalization time
(55%). For surgical patients, hospitalization varied in the interven-
tion group from four (Granger et al., 2013) to nine days (Brocki et al.,
2014), compared to six (Granger et al., 2013) to eleven days (Arbane
et al., 2011) in the control group. Adverse events were absent (Coats
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Table  4
Results of methodological quality according to ‘the Cochrane risk of bias tool’.
First author year Randomization
(selection bias)
Equal groups
(selection bias)
Blinding of
participants and
personnel
(performance
bias)
Blinding of
outcome
assessment
(detection bias)
Selective
drop-out
(attrition bias)
Selective
reporting
(reporting bias)
Methodological
quality
Andersen 2011 + NA NA NA − − Mode-rate
Andersen 2013 + NA NA NA + − Low
Arbane 2011 − − + − + + Low
Arbane 2014 + − + + + + Low
Brocki  2014 − − + − − − High
Cheville 2013 + − + + − + Low
Coats  2013 + NA NA NA − − Mode-rate
Granger 2013 − + + − + + Low
Hoffman 2014 + NA NA NA − − Mode-rate
Kuehr  2014 + NA NA NA + − Low
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Quist  2012 + NA NA 
isk of bias: + ‘present’, − ‘absent’; Methodological quality: present bias ≤17% ‘high’, 
t al., 2013; Quist et al., 2012) or occurred infrequently during the
ostoperative period (Arbane et al., 2011).
.3. Qualitative assessment
Only one study (9%) had a high methodological quality and was
t risk for performance bias as participants nor personnel were
linded (Table 4; Cochrane Statistical Methods Group and Cochrane
ias Methods Group, 2011a; Brocki et al., 2014). Therapeutic valid-
ty was low in this study due to insufficient eligibility criteria for
herapist and setting, rationale for the training program, and mon-
toring or personalization of the intervention (Table 5; Hoogeboom
t al., 2012). A moderate methodological quality was found in two
ehabilitation studies and one prehabilitation study (45%), where
specially selection bias could influence study outcomes (Andersen
t al., 2011; Coats et al., 2013; Hoffman et al., 2014). Additionally,
herapeutic validity was  high in all studies. In the seven remaining
ehabilitation studies, a low methodological quality was found due
o selection (Andersen et al., 2013; Arbane et al., 2014; Cheville
t al., 2013; Granger et al., 2013; Kuehr et al., 2014; Quist et al.,
012), reporting (Arbane et al., 2011, 2014; Cheville et al., 2013;
ranger et al., 2013; Quist et al., 2012), performance (Arbane et al.,
011, 2014; Brocki et al., 2014; Cheville et al., 2013; Granger et al.,
013), and attrition bias (Andersen et al., 2013; Arbane et al., 2011,
014; Granger et al., 2013; Kuehr et al., 2014; Quist et al., 2012). Of
hese seven studies, three had a low therapeutic validity due to lack
f eligibility criteria (Arbane et al., 2011, 2014; Kuehr et al., 2014;
uist et al., 2012), lack of rationale for the content and intensity
f the program (Arbane et al., 2011; Quist et al., 2012), or no per-
onalized exercises (Arbane et al., 2014; Kuehr et al., 2014; Quist
t al., 2012). The three studies assessing home-based training alone
ad a high therapeutic validity, and a moderate (Coats et al., 2013;
offman et al., 2014), and low (Cheville et al., 2013) methodologi-
al quality. The interobsever agreement for methodological quality
as very good (kappa 0.80) and for therapeutic validity good (kappa
.76).
Across included studies, only one described specific demands for
herapist and setting (Hoffman et al., 2014) and four did personalize
xercises (Andersen et al., 2013; Arbane et al., 2014; Granger et al.,
013; Hoffman et al., 2014). Selective dropout in six studies could
ave led to attrition bias (Andersen et al., 2013; Arbane et al., 2011,
014; Granger et al., 2013; Kuehr et al., 2014; Quist et al., 2012).
ive studies did not display results entirely or did not report on
ignificance, thereby inducing reporting bias (Arbane et al., 2011,
014; Cheville et al., 2013; Granger et al., 2013; Quist et al., 2012).
he included randomized controlled trials did not perform blind-
ng for randomization, participants, or personnel. Therefore, theseNA + + Low
% ‘moderate’, ≥50% ‘low’; NA ‘not applicable’.
studies were at risk for performance and detection bias (Arbane
et al., 2011, 2014; Brocki et al., 2014; Cheville et al., 2013; Granger
et al., 2013).
4. Discussion
The aim of this systematic review was  to evaluate feasibility
and effectiveness of prehabilitation and rehabilitation including a
home-based component for patients with NSCLC and to describe
physical fitness, adherence, treatment tolerance, and recovery.
4.1. Summary of evidence
Ten rehabilitation studies and one prehabilitation study were
included (451 patients with NSCLC). Patients included in this
review were diagnosed with stage I–IV disease, and most under-
went surgery with or without (neo)adjuvant treatment (308 of 496
(62%)). However, studies in which patients received radiotherapy,
chemotherapy, chemoradiotherapy, or palliative care were also
included. Rehabilitation studies including a home-based compo-
nent showed significantly or clinically relevant increased physical
fitness. Home-based prehabilitation may  increase physical fitness
as well, although only one published study was found. Patient
adherence and exercise adherence were generally higher and suf-
ficient in home-based interventions compared to combinations of
home-based, intramural- and/or extramural training. It remains
unclear wether home-based prehabilitation can lead to less adverse
events or hospitalization time, while rehabilitation including a
home-based component might improve recovery after treatment.
Highest patient adherence and/or exercise adherence together
with significant or clinically relevant improvements in physical fit-
ness can be reached by home-based interventions, as was seen in
three studies including home-based interventions only (Cheville
et al., 2013; Coats et al., 2013; Hoffman et al., 2014). However,
it should be mentioned that these were two pilot studies (Coats
et al., 2013; Hoffman et al., 2014) and one randomized controlled
trial (Cheville et al., 2013), and other included studies with a home-
based component did not always report compliance of home-based
exercises (Andersen et al., 2011, 2013; Arbane et al., 2011, 2014;
Granger et al., 2013). Still, physical fitness did not differ between
home-based training alone and those with additional extramural
sessions (Brocki et al., 2014). Probably, newly diagnosed lung can-
cer patients show interest and motivation for exercise programs,
in which home-based training during treatment was  preferred
(Karvinen et al., 2016). As patients with NSCLC are often older and
frail (Hsu et al., 2015; Semrau et al., 2014; Hoogeboom et al., 2012),
commuting and accessibility to in- and outpatient facilities hin-
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der participation in clinic-based exercise programs (Oosting et al.,
2012). Therefore, exercise programs should be delivered at the
patient’s own living situation to optimize adherence (Oosting et al.,
2012). Furthermore, regular supervision (Dalal et al., 2010), and
a personalized training program (Spruit et al., 2013; Royal Dutch
Physiotherapy Society, 2008; Netherlands Cancer Registry, 2011;
Pouwels et al., 2015) can further increase adherence rates by facil-
itating motivation and a physically active lifestyle, as is recognized
by the CONTENT scale (Hoogeboom et al., 2012; Herbert and Bø,
2005). At the time of cancer diagnosis, patients are more suscep-
tible to persue a healthy lifestyle to optimize treatment outcomes
and general health (Westmaas et al., 2015). In two included studies,
increased physical fitness maintained several weeks (Kuehr et al.,
2014), and ten months (Brocki et al., 2014) after the intervention
without additional exercise instructions. This was previously found
in surgical patients with NSCLC receiving prehabilitation and/or
rehabilitation ((p)rehabilitation), although home-based exercises
were not included in these studies (Ni et al., 2016; Cavalheri et al.,
2014). Despite the fact that improvement of treatment tolerance or
recovery is the driving force behind the concept of (p)rehabilitation,
it was either not reported or reported by diverse parameters (num-
ber of complications or hospitalization days). Trials mainly included
fit and selected patients without comorbidities, leaving older and
high-risk patients underrepresented (Kilari et al., 2016).
Most rehabilitation studies combine intramural and/or extra-
mural training with home-based exercises. Also, there is hetero-
geneity in the contents of training sessions, and their planning
and sequences. Higher training intensity and use of devices such
as bicycles and treadmills were more present in intramural and
extramural sessions, whereas home-based sessions included lower
intensity and more simple instruments. The broad patient popula-
tion provided in our review included different stages of disease,
treatment options, age groups, and physical fitness. This het-
erogeneity reflects everyday clinical care and probably explains
the observed wide range of effect sizes and maximal capable
improvements in treatment outcomes. However, it hinders the
interpretation of summarized results, and effects of interactions
between training contents and patient characteristics are war-
ranted. Furthermore, natural physical recovery comes into play as
increased physical fitness cannot be explained by the intervention
solely, emphasizing the importance of control groups in studies.
4.2. Strengths and limitations
Strengths of this study are the independent literature search,
selection, and data extraction by two  reviewers with good agree-
ment, thereby preventing errors in study and data selection, and
limiting reporting bias (Cochrane Statistical Methods Group and
Cochrane Bias Methods Group, 2011b). Also, therapeutic validity
was assessed, providing more insight in reported study out-
comes, as a low therapeutic quality might explain decreased
effectiveness of the intervention compared to what was expected
(Hoogeboom et al., 2012). Nevertheless, the outcomes of this sys-
tematic review should be interpreted carefully due to several
contstraints. Only three studies incorporated home-based training
alone for (p)rehabilitation. The eight remaining studies included
home-based, intramural- and/or extramural components and as
a result, seperate effects of a home-based training component
could not be attributed. Also, several pilot studies were included.
This means that evidence is still lacking and powered randomized
controlled trials are required. Especially for home-based prehabili-
tation, not all potential eligible studies were available. As negative
and non-significant outcomes are less likely to be published, pub-
lication bias could lead to a more positive scope of outcomes.
Regarding methodological quality, cut off values were not present
and categories were arbitrarily chosen. This could lead to an over-
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stimation of methodological quality as some types of bias are
etermined by more than one study characteristic (The Cochrane
ollaboration, 2011). Moreover, some components did apply to
andomized controlled trials only. Since clinical and statistical
eterogeneity impeded the interpretation of patient characteris-
ics and exercise contents, the internal validity of summarized
ffect sizes for the 6MWT  distance is questionable. Therefore, a
eta-analysis could not be performed despite the vast number of
tudies and patients included (Herbert and Bø, 2005). Furthermore,
he goal of (p)rehabilitation will be different for patients receiv-
ng surgery, radiotherapy, chemoradiotherapy, chemotherapy, and
alliative treatment. As the included patient group was heteroge-
eous with different prognoses and applied treatment regimens,
arious effects can be expected which cannot be explained by (lack
f) effectiveness of (p)rehabilitation.
Several types of bias could influence methodological quality.
election bias in non-randomized studies and omission of blind-
ng participants or personnel could lead to increased motivation
nd more positive study results. Although it is almost impossible
o perform blinding during physical interventions, one study was
ble to apply this on outcome assessors and patients (Granger et al.,
013). Attrition bias could have influenced results, although most
atients indicated a reason for withdrawal. Nevertheless, some
ere unknown and could disguise potential negative treatment
ffects such as worse physical functioning or fatigue (Ni et al.,
016; Pouwels et al., 2015). Selective reporting is a concern as
ata regarding statistical significance were not always displayed for
he home-based component specifically. Yet, evaluating whether
here was a clinically relevant improvement in cardiorespiratory
tness after (p)rehabilitation was possible for all studies using the
MWT  distance. As only physical fitness was included in the search
trategy, missing values for adherence treatment tolerance, and
ecovery were foreseen.
With regard to therapeutic validity, small sample sizes and
atient cohort studies allow researchers to provide a flexible train-
ng scheme which can be easily monitored and adapted, thereby
ncreasing patient and exercise adherence (Dalal et al., 2010;
ouwels et al., 2015). As a result, effect rates could be based on
ndividually optimized, but slightly incomparable exercise pro-
rams (Hoogeboom et al., 2012; Herbert and Bø, 2005). Mainly
arger studies disregard components like personalization of exer-
ises and supervision for increasing quality and effectiveness of the
ntervention. Absolute training effects are more easy to compare in
on-personalized fully structured training sessions (Thorsen et al.,
005), resulting in higher methodological quality. However, the
ain goal of home-based (p)rehabilitation should be to enhance
nd preserve wellbeing and everyday life in patients with NSCLC
Salander and Lilliehorn, 2016). Therefore, a patient tailored pro-
ram with a necessity-based design should be at best interest,
ogether with the highest therapeutical and methodological quality
Gridelli et al., 2007; Kilari et al., 2016). Furthermore, all patients
ith NSCLC can benefit from increasing endurance and muscle
trength in order to optimize treatment outcomes by home-based
p)rehabilitation. However, the selection of patients should mainly
ocus on older and high-risk patients and how to increase acces-
ibility to home-based, supervised, and personalized sessions in
rder to maximize training, physical fitness, adherence, treatment
olerance, and recovery (Kilari et al., 2016).
In conclusion, this systematic review showed positive and
ncouraging results of (home-based) (p)rehabilitation on physical
tness for patients with NSCLC. Although included studies varied
n quality, and quantity, results of this review indicate that com-
ining (home-based) resistance and endurance training, as well as
upervision and personalization, seem necessary to optimize phys-
cal fitness, adherence, treatment tolerance, and recovery. Although
ifferent training contexts have been included in this review,logy/Hematology 114 (2017) 63–76 75
home-based training alone has not been studied extensively and
several studies were underpowerd. Therefore, additional random-
ized controlled trials are required. This sets priority for prospective
trials including older and high-risk patients with NSCLC, in which
supervision, personalization, and high methodological and thera-
peutic quality in a home-based context are investigated. Ultimately,
more evidence for home-based (p)rehabilitation can be gathered
leading to improved physical fitness, patient adherence, exercise
adherence, and especially recovery and treatment tolerance in this
predominantly high-risk patient group.
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